• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Canada·Healthcare·NRTSF
Share

Nobilis Health Corp. Stocks

$ 0Last Updated 23.10.2026

Issuer Rating

2/7
Performance

Average

Risk

Critical

Recommendation

Sell

Market Cap

$ 78

$ 0
Key Takeaways

Risk factor

Critical default risk

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Nobilis Health Corp. focuses on the development and operation of ambulatory surgical centers, providing cutting-edge surgical solutions. The company owns and manages a diverse range of facilities, including both outpatient and acute care settings. Its business operations are divided into two primary segments: Medical Services and Marketing Services. The Medical Services division is responsible for the management of hospitals, outpatient clinics, and various other healthcare offerings. Complementing this, the Marketing Services segment delivers promotional strategies, patient educational programs, and comprehensive patient care coordination. Nobilis Health Corp. was established on March 16, 2007, and its corporate headquarters are located in Houston, TX.

Company Valuation

Greatly undervalued
7/7

Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

29.10.2026 09:01

Boeing's stock has fallen 23% since the start of the year. Is it worth buying on the dip?

29.10.2026 06:59

"Mega Deal": Marvell Is in Talks to Acquire Lumentum, a Developer of Data Center Optics

29.10.2026 01:34

Microsoft Beat Forecasts for Cloud Revenue

29.10.2026 01:17

"The Moment of Truth": Alphabet Shares Plunge 10% After Disappointing Earnings Report

29.10.2026 01:07

The U.S. Federal Reserve will reduce the number of interest rate meetings starting in 2027

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026